List of HU cannabinoids

From WikiMD's WELLNESSPEDIA

HU cannabinoids are a series of synthetic cannabinoids that were first synthesized in the 1960s in the Weizmann Institute of Science by Professor Raphael Mechoulam and his team. The term "HU" stands for Hebrew University, where Professor Mechoulam was working when the compounds were developed.

Overview[edit]

HU cannabinoids are a group of compounds that are structurally similar to THC, the active ingredient in cannabis. They are part of a larger group of compounds known as cannabinoids, which also includes natural compounds found in the cannabis plant, as well as synthetic compounds created in the lab.

List of HU Cannabinoids[edit]

HU-210[edit]

HU-210 is a synthetic cannabinoid that is approximately 100 times more potent than THC. It has been used in research to study the effects of cannabinoids on the brain and body.

HU-211[edit]

HU-211 is a non-psychoactive synthetic cannabinoid that has been studied for its potential use in treating brain injuries and strokes.

HU-308[edit]

HU-308 is a synthetic cannabinoid that has been studied for its potential use in treating inflammation and pain.

HU-331[edit]

HU-331 is a synthetic cannabinoid that has been studied for its potential use in treating cancer.

See Also[edit]

References[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.